Milpitas, CA, United States of America

Atul Saxena

USPTO Granted Patents = 3 

 

Average Co-Inventor Count = 4.8

ph-index = 2

Forward Citations = 22(Granted Patents)


Company Filing History:


Years Active: 2014-2017

Loading Chart...
Loading Chart...
3 patents (USPTO):Explore Patents

Title: Atul Saxena: Innovator in Pharmaceutical Formulations

Introduction

Atul Saxena is a notable inventor based in Milpitas, California. He has made significant contributions to the field of pharmaceuticals, particularly in the development of innovative formulations for treating infectious diseases. With a total of three patents to his name, Saxena's work is paving the way for advancements in medical treatments.

Latest Patents

Saxena's latest patents include a groundbreaking formulation utilizing gallium for the treatment and prevention of infectious diseases. This method and composition target bacterial infections caused by both gram-negative and gram-positive bacteria, including multidrug-resistant strains. His second patent focuses on highly dispersible powders, detailing a method for selecting pharmaceutically acceptable excipients that facilitate the production of these powders through spray drying.

Career Highlights

Atul Saxena is currently employed at Aridis Pharmaceuticals, where he continues to innovate in the pharmaceutical sector. His work is characterized by a commitment to improving treatment options for patients suffering from bacterial infections.

Collaborations

Saxena collaborates with talented professionals in his field, including Satoshi Ohtake and Vu Truong-Le. These partnerships enhance the research and development efforts at Aridis Pharmaceuticals.

Conclusion

Atul Saxena's contributions to pharmaceutical formulations demonstrate his dedication to advancing medical science. His innovative patents are crucial in the fight against infectious diseases, showcasing the importance of research and collaboration in the field.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…